ClinicalTrials.gg
CompletedNCT05074654Updated Jan 19, 2022

Urdu Version of Neck Pain and Disability Scale (NPAD)

An observational study in Neck Pain and Neck Disorder, sponsored by Riphah International University. Completed at 1 site in Pakistan. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2022-01-19.

Sponsored by Riphah International University · Observational

Study type
Observational
Model
Ecologic or community
Time perspective
Cross-sectional
Enrollment
81
Ages
18 Years to 65 Years
Sex
All
01

Study summary

In this study, the examiners will investigate the reliability and validity of neck pain and disability scale in Urdu language in Pakistani patients with neck pain and related disability.

Read the detailed description

This study's objective is to translate the Neck Pain and Disability Scale (NPAD) into Urdu and evaluate its reliability and validity in Pakistani neck pain individuals. This cross-sectional survey will employ convenience sampling to choose participants.

This study's findings will assist determine the NPAD's reliability and validity in individuals with neck pain and impairment. This scale's reliability will be evaluated utilising internal consistency and test-retest methods. Cronbach's alpha value checks internal consistency. The interclass correlation will be used to examine the test-retest reliability.

02

Conditions studied

  • Neck Pain
  • Neck Disorder

Browse trials for

Keywords

  • Neck pain and disability scale
  • Pain
  • Disability
  • Reliability and validity
  • population with neck pain
03

In context

Neck Pain

1,259 studies on the registry are indexed under Neck Pain; 256 are open to participants now.

This study's enrollment of 81 is below the median of 93 across 218 observational studies indexed under Neck Pain.

Browse Neck Pain studies →

Lead sponsor

Riphah International University is the lead sponsor of 2,176 studies on the registry; 637 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

People with non-specific chronic neck pain that interferes with their social, recreational, functional, vocational and emotional aspects of living. Chronic non-specific neck pain is related to limited cervical mobility, impaired function, neck muscles myofascial pain syndrome, and stress at work. The aforementioned factors are strongly related and may lead to a negative impact on health-related quality of life.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Individuals including both male and females between age 18 and 65 years.
  • Participants with non-specific chronic pain of neck (>3 months in duration).
  • Individuals with sufficient knowledge and understanding of Urdu language.

Exclusion criteria

Exclusion Criteria

  • Individuals with history of cervical surgery.
  • Individuals with cervical myelopathy or radiculopathy, regional tumors, disc herniation, vertebral fractures, traumatic injuries, cardiovascular and pulmonary diseases, pregnancy or any behavioral problems were excluded
  • Individuals with any pertinent comorbidities including heart attack, cancer, cognitive impairment or infection were also excluded. herniation, vertebral fractures, traumatic injuries, cardiovascular and pulmonary diseases, pregnancy or any behavioral problems were excluded
  • Individuals with any pertinent comorbidities including heart attack, cancer, cognitive impairment or infection were also excluded.
05

Study design

Observational model
Ecologic or community
Time perspective
Cross-sectional
Enrollment
81 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Neck Pain and Disability scale

    The Neck Pain and Disability Scale is a multidimensional configuration measure that contains a 20-item questionnaire to assess neck pain and disability. This scale measures neck mobility and severity difficulties, as well as the impact of neck injuries on everyday activities.

    Time frame: 1st day

Secondary outcomes

  1. Neck Disability Index

    This tool assesses the quality of pain, lifting, personal care, job activities, headaches, sleep, drive, and leisure activities. Each item is graded from 0 to 5. The Neck Disability Index is a one-dimensional evaluation instrument designed to show how neck pain affects activities and capability. This is a reliable and useful self-declared estimate tool for neck problems. This scale may be used to assess a patient's current condition and progress throughout therapy.

    Time frame: 1st day

  2. Pain Disability Index

    The Pain Disability Index is an authentic simple measure of indiscriminate pain and disability and is used for the evaluation of the influence of pain on the capability of an individual's participation skills in everyday important activities. It has also been used in assessment of the patients before interventions and then monitoring them over time to evaluate the efficacy of interventions. This scale comprises of 7 sections which include family, home responsibilities, recreation, occupation, sexual and social activities, self-care and life support and these items are totaled into a score between 0-70.

    Time frame: 1st day

  3. Visual Analogue Scale

    The Visual Analogue Scale is a unique instrument for assessing chronic and acute pain as well as pain perception. It is a scale that assesses the frequency and severity of pain experienced by a person. Patient selects a position on the line that best represents their pain perception.

    Time frame: 1st day

07

Study locations

1 site
  • Ripah International University
    Faisalabad, Punjab Province 38000, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 19, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05074654
Responsible party
Sponsor
First posted
Oct 12, 2021
Start date
Mar 1, 2021
Primary completion
Oct 15, 2021
Completion
Oct 15, 2021
Last update
Jan 19, 2022

Study contacts

Muhammad Kashif
study chair · Riphah International University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion